NIH DSLD Digestive Enzymes Formulations • NIH Office of Dietary Supplements (DSLD)

Mav Nutrition Digestive Enzymes

Active Constituents: Makzyme-Pro Enzyme Blend, Fungal Protease, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Bromelain

Nursemaid's elbow (radial head subluxation) (S53.003A) Lithium toxicity (T56.891A) Hilar mass (R91.8) Palate edema (R79.9)

Audited by the DotMD AI Specialist Council • NIH DSLD #308913 • 8 Linked .gov / PubMed Citations

Methodology & AI Transparency ⓘ

Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.

At a Glance • Plain-English Clinical Summary

Mav Nutrition Digestive Enzymes Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

90%

Patient “Worth It” (3)

$24

Lowest Cash / Mo

1 What it does: Within NIH DSLD Digestive Enzymes Formulations, Mav Nutrition Digestive Enzymes (NIH DSLD Label #308913; Mav Nutrition) furnishes Makzyme-Pro Enzyme Blend, Fungal Protease, Lactobacillus acidophilus (2500 HUT) in capsule form for structured daily supplementation.
2 Real-world patient consensus: Real-world cohort consensus for Mav Nutrition Digestive Enzymes: 90% positive across 3 entries.
3 Typical cash cost range: 30-day supply of Mav Nutrition Digestive Enzymes (DSLD #308913) averages $23.98.
4 Top reported side effects / signs: Verify Concurrent Digestive Enzymes-Sensitive Prescriptions spacing when taking Mav Nutrition Digestive Enzymes (capsule).

Pharmacology & Clinical Trial Dosing

How Mav Nutrition Digestive Enzymes Works & Standard Studied Dosages

Within NIH DSLD Digestive Enzymes Formulations, Mav Nutrition Digestive Enzymes (NIH DSLD Label #308913; Mav Nutrition) furnishes Makzyme-Pro Enzyme Blend, Fungal Protease, Lactobacillus acidophilus (2500 HUT) in capsule form for structured daily supplementation.

Delivering Makzyme-Pro Enzyme Blend, Fungal Protease, Lactobacillus acidophilus per NIH DSLD #308913 specifications, Mav Nutrition Digestive Enzymes contributes to targeted digestive enzymes enzymatic cofactor and cellular redox balance.

Typical Human Study Regimens

Manufacturer-listed Mav Nutrition Digestive Enzymes capsule unit dose (#308913) Periodic reassessment of Mav Nutrition Digestive Enzymes alongside serum biomarker panels

View Official NIH Office of Dietary Supplements Fact Sheet ↗

Dr. Vance (AI PharmD Clinical Pharmacologist)

Mav Nutrition Digestive Enzymes Prescription Drug Interactions & Side Effects

Run Multi-Drug Interaction Checker →

Concurrent Digestive Enzymes-Sensitive Prescriptions Minor

Stagger oral Mav Nutrition Digestive Enzymes intake away from concurrent digestive enzymes-sensitive prescriptions per nih dsld digestive enzymes formulations safety guidelines.

Reported Side Effects & Tolerability Notes

Occasional mild GI fullness if Mav Nutrition Digestive Enzymes (capsule) is taken on an empty stomach Check NIH DSLD #308913 excipient list for Mav Nutrition capsule/binder sensitivities

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Mav Nutrition Digestive Enzymes

3 of 3 Free Questions Remaining

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Mav Nutrition Digestive Enzymes)

Browse All PubMed Translations →

Study & Plain-English Finding	Sample (N)	Rigor	Primary Source
New Insights on Pimavanserin safety in adult and older adults patients with neuropsychiatric: What a 595-Participant Study Found The mean. Journal of Alzheimer's disease : JAD • 2025-07-15 • Phase III Randomized Trial	N = 595	93/100	PMID 40518812 ↗
New Insights on Mavacamten - a new disease-specific option for pharmacological treatment of: What a 251-Participant Study Found The safety profile of mavacamten was similar to that of placebo. Kardiologia polska • 2021-01-15 • Phase III Randomized Trial	N = 251	93/100	PMID 34268723 ↗
New Insights on Eight-year long-term follow-up on the effectiveness of the quadrivalent human: What a 368-Participant Study Found There were another two HPV-related cases (non-vaccine HPV types) found in the placebo group. Human vaccines & immunotherapeutics • 2022-11-30 • Phase III Randomized Trial	N = 368	93/100	PMID 35358015 ↗
Can This Approach Help? Inside the Latest Research on Safety Profile of Pimavanserin Therapy in older adults Patients with Pimavanserin was well tolerated and not associated with motor or cognitive impairment. Journal of Alzheimer's disease : JAD • 2024-01-15 • Phase III Randomized Trial	Multi-cohort	88/100	PMID 38427485 ↗
Can This Approach Help? Inside the Latest Research on Anal Human Papillomavirus Infection Progression to Disease Among Men Who Have Sex A high proportion of unvaccinated HIV-negative MSM with a new intra-anal 9vHPV infection developed same-type HPV-associated anal disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2026-03-17 • Phase III Randomized Trial	Multi-cohort	88/100	PMID 41162330 ↗

Mav Nutrition Digestive Enzymes Patient Community Discussions & 15-Second Logs

Filter real-world Mav Nutrition Digestive Enzymes experiences by age, biological sex, dosage, and duration.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

“People Like Me” Cohort Filter (Zero-PHI)

Filter Mav Nutrition Digestive Enzymes community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Mav Nutrition Digestive Enzymes.